Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human GPR3 Stable Cell Line

    [CAT#: S01YF-0923-PY155]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    GPR3
    Target Family
    Orphan Family
    Target Protein Species
    Rat
    Host Cell Type
    Rat cerebellar granule neurons;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    Metabolic Research
    Related Diseases
    Pituitary Adenoma 2, Growth Hormone-Secreting;Premature Menopause
    Gene ID
    Rat: 266769
    UniProt ID
    Rat: Q8K1Q3

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    GPR3 is a constitutively active receptor that plays significant roles in various cellular processes. Recent research has shown that GPR3 drives adipose thermogenesis through lipolysis-induced expression. Moreover, GPR3 signaling has been found to ameliorate amyloid pathology in preclinical Alzheimer's disease models, suggesting its potential therapeutic role in neurodegenerative disorders. Another study has highlighted the role of GPR3 in T cell stimulation, indicating its importance in immune responses.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human GPR3 Stable Cell Line (S01YF-0923-PY155). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Charles (Verified Customer)

    What is the role of the N terminus of GPR3 in signaling activity? Apr 12 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    The N terminus of GPR3 confers intrinsic signaling activity, leading to continuous Gs-coupling and cAMP production without needing an exogenous ligand. Apr 12 2021

    chat Linda (Verified Customer)

    How does biased GPR3 signaling impact Alzheimer's disease pathology? Nov 01 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Biased GPR3 signaling reduces Alzheimer's disease pathology and induces glial activation without affecting basal anxiety levels or cognitive function. Nov 01 2021

    Published Data

    Fig.1 GPR3 of exogenous origin exerts a moderating effect on the proliferation of cerebellar granule neurons in rodents induced by Shh, demonstrating a partial inhibitory influence on this cellular process.

    Rat cerebellum-derived GCPs at postnatal day 7 underwent electroporation with either a GPR3/EGFP vector or a control vector via the AMAXA nucleofector system. Subsequently, Shh (1 µg/ml) was introduced six hours later. Thirty hours into the experiment, BrdU (10 µM final concentration) was administered 12 hours before fixation. Evaluation of cell proliferation was conducted by assessing BrdU incorporation using immunohistochemistry with a specific BrdU monoclonal antibody (displayed in panels a and b). As a positive control, dbcAMP (100 µM) was employed as a chemical cAMP activator. Panel a illustrates representative fields from the Shh and control vector group (top row), Shh and GPR3/EGFP-electroporated group (middle row), and the Shh, control vector group, and dbcAMP (bottom row), visualized through BrdU immunohistochemistry (in red), EGFP fluorescence (in green), and the merged image. Each dish (n = 3) selected five random fields, with at least one hundred GFP-positive neurons counted in each field. Additionally, doubly labeled cells (appearing in yellow) were enumerated per dish. The results were expressed as the percentage of doubly-labeled cells among the total GFP-positive cells in the Shh+GPR3 group or Shh+GPR3+dbcAMP groups, in comparison to the Shh group (as shown in panel b). Simultaneously, cell proliferation was assessed using an ELISA assay based on BrdU incorporation during DNA synthesis (Panel C). Variations between the percentages of cells in panel b and c are likely attributed to differences in the assays employed, involving visual counting versus colorimetry-based counting.

    Ref: Tanaka, Shigeru, et al. "The Gs-linked receptor GPR3 inhibits the proliferation of cerebellar granule cells during postnatal development." PloS one 4.6 (2009): e5922.

    Pubmed: 19526062

    DOI: 10.1371/journal.pone.0005922

    Research Highlights

    Jiang Y, et al. "Chronic stress induces meiotic arrest failure and ovarian reserve decline via the ." Frontiers in endocrinology, 2023.
    The causal role of chronic stress in female subfertility is of interest, though the mechanisms driving this phenomenon remain unclear. In a recent study, researchers examined the impact of chronic stress on the cyclic adenosine 3',5'-monophosphate (cAMP) signaling pathway in mice, resulting in an observed decline in ovarian reserve. Utilizing a restraint stress model over the course of 8 weeks, the stress-exposed group displayed an elongated estrous cycle and a significant increase in the number of atretic follicles. Furthermore, stress-exposed oocytes showed signs of meiotic arrest failure (MAF) with condensed metaphase chromosomes, assembled spindles or polar bodies. Analysis using the CUBIC method confirmed a significant decrease in both quiescent and growing oocytes in the stress group. Subsequent examination of meiotic arrest maintenance pathways via real-time quantitative polymerase chain reaction (RT-qPCR) revealed downregulation of Gpr3, Nppc, and Npr2 in the stress group. Overall, these results suggest that inhibited cAMP production contributes to MAF and a decline in ovarian reserve. This study provides a better understanding of the mechanisms underlying chronic stress-induced oocyte loss and possible targets for preserving ovarian reserve.
    Pubmed: 37720535   DOI: 10.3389/fendo.2023.1177061

    Lu Y, et al. "Molecular insights into orphan G protein-coupled receptors relevant to ." British journal of pharmacology, 2023.
    This article focuses on the relationship between GPR3, GPR6, GPR12, GPR52, GPR85, GPR88, and GPR139 and schizophrenia. The authors review the expression, signalling mechanisms, and cellular function of these receptors, along with the development of small molecule therapeutics and structural insights. Through this review, they aim to present the current evidence and potential for new classes of therapeutics for schizophrenia.
    Pubmed: 37605621   DOI: 10.1111/bph.16221

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare